 |
| |
| Did you know direct-to-patient, remote trials, site-less trials, and digital trials are different ways of saying 'trial success' and 'positive patient experiences'? Regardless of which terminology you use to define this new trend one thing is clear, by harnessing new trial formats we can create unprecedented change in patient data flow and quality, improve patient recruitment and engagement, reduce drop out, improve consent and patient reporting and tremendously improve trial monitoring. |
| |
| CBI’s Direct-to-Patient Clinical Trials event, taking place August 9-10 in Philadelphia, addresses these groundbreaking trials to help you keep pace with a rapidly changing frontier regardless of what terminology you utilize. |
| |
| Featured Subject Matter Experts, Include: |
|
| • |
Craig Lipset, Head of Clinical Innovation, Pfizer Inc. |
| • |
Nnamdi Peter Ezeanochie, Senior Manager, Behavior Science, Johnson & Johnson Health and Wellness Solutions |
| • |
Jennifer Goldsack, Senior Project Manager, Clinical Trials Transformation Initiative |
| • |
Aman Thukral, Assistant Director, Strategy & Innovation, Clinical Data Sciences, AbbVie |
| • |
Elena Izmailova, Data Science Institute, Senor Director, Takeda |
| • |
Joe Kim, Senior Adviser, Clinical Innovation, Eli Lily & Company |
| • |
Beth Zaharoff, Director, Patient Focused Drug Development, Tesaro |
| • |
Ashish Atreja, Assistant Professor and Chief Innovation Officer, Icahn School of Medicine at Mount Sinai |
| • |
Jesse Bakker, Senior Manager, Clinical Trials, Phillips Respironics |
| • |
Lisa Berdan, Director, Global Megatrials, Duke University |
| • |
Bradley S. Davidsen, Associate, Epstein Becker & Green |
| • |
And many more! |
|
| |
| Key Benefits: |
|
| • |
Develop direct-to-patient trial protocols to improve patient experience and trial success rates |
| • |
Ensure data quality, enhance data collection, promote interoperability and eliminate redundancies |
| • |
Incorporate wearable, mobile and fit-for-purpose devices into trials for patient convenience |
| • |
Simplify and centralize your trial data collection stream from all sources |
| • |
Translate patient feedback into trial design |
| • |
Gain insight into the legal landscape of direct-to-patient trials from home medication shipments to patient privacy |
| • |
Gain insights into technology trends and capabilities to enhance trial performance and outcomes |
| • |
Overcome regulatory challenges in direct-to-patient trial supply chain |
|
| |
| Don’t be left out of the conversation. Register by Friday, August 3rd and receive $300* off the standard rate with promo code ACT300. |
|
| *Offer expires August 3, 2018; applies to standard rates only and may not be combined with other offers, category rates, and promotions or applied to an existing registration. |
| |
|
|